94-13397. Importation of Controlled Substances; Application  

  • [Federal Register Volume 59, Number 105 (Thursday, June 2, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-13397]
    
    
    [[Page Unknown]]
    
    [Federal Register: June 2, 1994]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Drug Enforcement Administration
    
     
    
    Importation of Controlled Substances; Application
    
        Pursuant to section 1008 of the Controlled Substances Import and 
    Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
    issuing a registration under this section to a bulk manufacturer of a 
    controlled substance in Schedule I or II and prior to issuing a 
    regulation under section 1002(a) authorizing the importation of such a 
    substance, provide manufacturers holding registrations for the bulk 
    manufacture of the substance an opportunity for a hearing.
        Therefore, in accordance with section 1311.42 of title 21, Code of 
    Federal Regulations (CFR), notice is hereby given that on April 15, 
    1994, Radian Corporation, 8501 Mopac Blvd., P.O. Box 201088, Austin, 
    Texas 78720, made application to the Drug Enforcement Administration to 
    be registered as an importer of the basic classes of controlled 
    substances listed below:
    
    ------------------------------------------------------------------------
                                                                  Schedule  
    ------------------------------------------------------------------------
    Drug:                                                                   
    Ibogaine (7260)...........................................  I           
    Dihydromorphine (9145)....................................  I           
    Cocaine (9041)............................................  II          
    Codeine (9050)............................................  II          
    Dextropropoxyphene, bulk (non-dosage forms) (9273)........  II          
    Morphine (9300)...........................................  II          
    Thebaine (9333)...........................................  II          
    Oxymorphone (9652)........................................  II          
    ------------------------------------------------------------------------
    
    
        The firm plans to import deuterated material not currently 
    available in the United States for manufacturing of exempt products.
        Any manufacturer holding, or applying for, registration as a bulk 
    manufacturer of this basic class of controlled substance may file 
    written comments on or objections to the application described above 
    and may, at the same time, file a written request for a hearing on such 
    application in accordance with 21 CFR 1301.54 in such form as 
    prescribed by 21 CFR 1316.47.
        Any such comments, objections, or requests for a hearing may be 
    addressed to the Deputy Assistant Administrator, Office of Diversion 
    Control, Drug Enforcement Administration, United States Department of 
    Justice, Washington, DC 20537, Attention: DEA Federal Register 
    Representative (CCR), and must be filed no later than July 5, 1994.
        This procedure is to be conducted simultaneously with and 
    independent of the procedures described in 21 CFR 1311.42 (b), (c), 
    (d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 
    (September 23, 1975), all applicants for registration to import a basic 
    class of any controlled substance in Schedule I or II are and will 
    continue to be required to demonstrate to the Deputy Assistant 
    Administrator, Office of Diversion Control, Drug Enforcement 
    Administration, that the requirements for such registration pursuant to 
    21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c), 
    (d), (e), and (f) are satisfied.
    
        Dated: May 23, 1994.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 94-13397 Filed 6-1-94; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
06/02/1994
Department:
Drug Enforcement Administration
Entry Type:
Uncategorized Document
Document Number:
94-13397
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: June 2, 1994